{
    "applicationNumber": "BR 11 2021 019478-9",
    "filingDate": "16/12/2019",
    "grantDate": null,
    "title": "PRIMEIRA, SEGUNDA E TERCEIRA PROTE\u00cdNAS DE FUS\u00c3O COMPREENDENDO ANTICORPOS ANTI-MESOTELINA, ANTI-CD3 E ANTI-EGFR, ANTICORPOS BIESPEC\u00cdFICO E TRIESPEC\u00cdFICO, COMPOSI\u00c7\u00c3OFARMAC\u00caUTICA QUE COMPREENDE OS MESMOS E USOS DAS DITAS PROTE\u00cdNAS E ANTICORPOS, BEM COMO DA DITA COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA PARA TRATAR C\u00c2NCER",
    "nationalPhaseDate": [
        "28/09/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT KR2019/017809",
        "pctDate": "16/12/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/826,442",
            "priorityDate": "29/03/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2649"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2656"
        }
    ],
    "inventors": [
        "YANGMI LIM",
        "SHINAI LEE",
        "JONGHWA WON",
        "YEA PARK",
        "AERIN YOON",
        "SUA LEE",
        "OKJAE LIM",
        "SOJUNG LIM",
        "MUNKYUNG KIM"
    ],
    "holders": [
        194843,
        85843
    ],
    "ipcCodes": [
        "A61P 35/00",
        "C07K 16/30",
        "A61K 39/00",
        "C07K 16/28"
    ]
}